Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pharma ETFs Soar on Robust Q2 Earnings

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

JNJ : 148.60 (+0.71%)
PFE : 38.45 (+0.47%)
MRK : 81.02 (-0.04%)
LLY : 152.93 (+0.03%)
BMY : 61.02 (-0.51%)
PPH : 63.76 (-0.93%)
PJP : 66.72 (+0.09%)
IHE : 163.81 (+0.43%)
XPH : 44.73 (+0.58%)
FTXH : 24.46 (+0.25%)
Nektar's (NKTR) Q2 Earnings Beat, Bempeg Makes Progress

Nektar (NKTR) reports encouraging second-quarter 2020 results. The company continues to progress with its pipeline candidates.

PFE : 38.45 (+0.47%)
MRK : 81.02 (-0.04%)
BMY : 61.02 (-0.51%)
NKTR : 21.85 (+1.58%)
A sleepy North Carolina city flexes its logistics muscle

City checks off many of the distribution center site boxes.

CSX : 72.93 (+0.91%)
CBRE : 44.02 (+4.19%)
PFE : 38.45 (+0.47%)
GLW : 31.85 (+0.03%)
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19

Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead's investigational antiviral remdesivir, as one of multiple external manufacturing...

PFE : 38.45 (+0.47%)
Ocular Drug Delivery Technology Market Threats, Phenomenal Growth Prospects and Opportunities|Alimera Sciences Inc, Valeant Pharmaceuticals International Inc and Clearside Biomedical Inc

AGN : 193.02 (+0.02%)
CLSD : 1.7600 (-1.68%)
NVS : 82.91 (-0.60%)
OCUL : 8.21 (-2.96%)
PFE : 38.45 (+0.47%)
VRX.TO : 30.80 (-3.33%)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020

and , /PRNewswire/ -ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate...

EPIX : 6.83 (+0.74%)
EPI.VN : 9.070 (+4.01%)
PFE : 38.45 (+0.47%)
Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program

Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program

PFE : 38.45 (+0.47%)
ACHV : 10.99 (-6.07%)
Global Vaccines Industry Landscape 2020-2027: Increase in Incidence of Both Viral and Bacterial Infectious Diseases

, /PRNewswire/ -- The report has been added to offering.

CSLLY : 98.4500 (-1.87%)
DSNKY : 88.3150 (+0.89%)
MRK : 81.02 (-0.04%)
MTZPY : 18.6000 (-0.13%)
PFE : 38.45 (+0.47%)
Mylan (MYL) Q2 Earnings Beat Estimates, Revenues Fall Y/Y

Mylan (MYL) beats on both earnings and revenues for the second quarter of 2020.

BIIB : 305.71 (+10.10%)
PFE : 38.45 (+0.47%)
MYL : 16.35 (-0.43%)
GSK : 40.79 (-0.44%)
Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020

Pfizer Inc. (NYSE: PFE) announced today that it will be holding its rescheduled Investor Day virtually over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to approximately 4:00 p.m. EDT and Tuesday,...

PFE : 38.45 (+0.47%)
Pfizer Inc (PFE) Approaches New Upside Target of $38.77

Shares of Pfizer Inc (NYSE:PFE) have bullishly opened above the pivot of $38.37 today and have reached the first resistance level of $38.61. Investors may be interested in a cross of the next upside pivot...

PFE : 38.45 (+0.47%)
Bristol-Myers (BMY) Q2 Earnings Beat, 2020 Earnings View Up

Bristol-Myers (BMY) beats on earnings and sales in the second quarter on the strength of Revlimid and Eliquis.

PFE : 38.45 (+0.47%)
MRK : 81.02 (-0.04%)
BMY : 61.02 (-0.51%)
XLRN : 99.12 (-6.89%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention

, /PRNewswire/ -- In the last 18 years, viral disease epidemics have across the globe. Today's pandemic is quickly adding to the number of deaths while seriously disrupting economies, businesses, and...

GILD : 69.35 (+0.78%)
AZN : 55.41 (-1.42%)
PFE : 38.45 (+0.47%)
LLY : 152.93 (+0.03%)
CRDL.TO : 2.22 (-1.33%)
CRTPF : 1.6500 (-2.94%)
Colorectal Cancer Drugs Market Research Report by Class - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ --Read the full report: The Global Colorectal Cancer Drugs Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 3.94%.Market Segmentation...

ABBV : 92.92 (+0.38%)
AMGN : 240.69 (-0.36%)
ALPMF : 15.7550 (-0.41%)
LLY : 152.93 (+0.03%)
MRK : 81.02 (-0.04%)
NVS : 82.91 (-0.60%)
PFE : 38.45 (+0.47%)
BioNTech (BNTX) to Report Q2 Earnings: What's in Store?

During BioNTech's (BNTX) upcoming Q2 earnings conference, investors will keep track of the advancement of its COVID-19 vaccine candidate being developed in partnership with Pfizer.

PFE : 38.45 (+0.47%)
BLUE : 63.48 (-0.56%)
ICPT : 48.75 (+3.33%)
BNTX : 77.00 (-0.10%)
Epizyme's (EPZM) Q2 Earnings and Revenues Miss Estimates

Epizyme (EPZM) reports a wider-than-expected loss and misses sales estimates in the second quarter of 2020.

PFE : 38.45 (+0.47%)
MRK : 81.02 (-0.04%)
NVS : 82.91 (-0.60%)
EPZM : 12.87 (+0.31%)
The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

SNY : 51.51 (+0.02%)
PFE : 38.45 (+0.47%)
MRNA : 74.10 (+0.46%)
LLY : 152.93 (+0.03%)
GSK : 40.79 (-0.44%)
BNTX : 77.00 (-0.10%)
Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate

Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate

PFE : 38.45 (+0.47%)
LORBRENA(R) (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer

Pfizer Inc. (NYSE:PFE) today announced that the Phase 3 CROWN study of LORBRENA(R) (lorlatinib) in people with previously untreated advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung...

PFE : 38.45 (+0.47%)
3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term Portfolio

Investors should consider adding a few large-cap names that are prepared to grow for years to come. These three stocks also pay dividends and provide exposure to three very different and vital industries......

NOC : 329.27 (+0.90%)
MSFT : 212.48 (-1.79%)
BA : 170.02 (-1.27%)
AAPL : 444.45 (-2.45%)
PFE : 38.45 (+0.47%)
MRK : 81.02 (-0.04%)
AMD : 84.85 (-2.15%)
LLY : 152.93 (+0.03%)
LMT : 385.62 (+1.55%)
NFLX : 494.73 (-2.82%)
ABBV : 92.92 (+0.38%)
SPOT : 252.12 (-1.25%)
ZM : 258.73 (-3.55%)

Van Meerten Stock Picks

The 5 Best MidCaps
I wanted to find the 5 Mid Caps that have had the best momentum over the past year so I used Barchart to sort the S&P 400 MidCap Stock Index for the stocks with the highest Weighted Alpha and technical buying signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar